1. Market Research
  2. > Therapy Market Trends
  3. > Lipid Modifying Drug Industry

Lipid Modifying Drug Industry Statistics

You might be interested in: Cardiovascular Disease, Hospital, Pharmaceutical, Healthcare, Stroke, Therapy, Statins, Analgesic, Opioid, Anti-Infective, Anti Rheumatic, Antiviral, Cardiovascular Drug, Hormone, Niacin.

1-10 of 38 reports for Lipid Modifying Drug

Opioid Market in the UK

  • January 2016
    48 pages
  • Analgesic  

    Opioid  

    Anti-Infective  

  • United Kingdom  

    Europe  

View report >

Cardiovascular Disease Statistics in the UK

  • January 2016
    64 pages
  • Cardiovascular ...  

    Therapy  

    Statins  

  • United Kingdom  

    United States  

View report >

Cardiovascular Disease Statistics in Norway

  • May 2016
    111 pages
  • Cardiovascular ...  

    Lipid Modifying...  

  • Norway  

    Europe  

View report >

Therapy Market in the UK - Forecast

  • September 2017
    131 pages
  • Therapy  

    Eye Disease  

    Autoimmune Dise...  

  • United Kingdom  

View report >

Analgesic Market

  • January 2017
    144 pages
  • Analgesic  

  • Norway  

    Europe  

View report >

Statins Market

  • January 2016
    11 pages
  • Statins  

    Lipid Modifying...  

View report >

Global Cardiovascular Disease Statistics

  • January 2016
    11 pages
  • Cardiovascular ...  

    Cholesterol  

  • World  

View report >

Healthcare Industry - Company Report, 2016

  • January 2016
    37 pages
  • Therapy  

    Monoclonal Anti...  

  • United Kingdom  

View report >

UK Demographic Analysis

  • December 2017
    127 pages
  • Healthcare  

  • United Kingdom  

View report >

Pharmaceutical Industry in Australia

  • February 2018
    8 pages
  • Health Services  

    Nursing Home  

  • Australia  

    Oceania  

    Netherlands  

View report >
1 report for Lipid Modifying Drug

Purchase Reports From Reputable Market Research Publishers

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor -Pipeline Insight, 2018

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor -Pipeline Insight, 2018

  • $ 1250
  • Industry report
  • January 2018
  • by Delve Insight

“Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor - Pipeline Insight, 2018” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario ...


ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on